Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Cell Cycle. 2016;15(6):819-26. doi: 10.1080/15384101.2016.1148836.
Cell Cycle. 2016.
PMID: 27029529
Free PMC article.
CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R, Kapur N, Mir H, Singh N, Lillard JW Jr, Singh S.
Singh R, et al.
Oncotarget. 2016 Feb 9;7(6):7343-53. doi: 10.18632/oncotarget.6944.
Oncotarget. 2016.
PMID: 26799186
Free PMC article.
Item in Clipboard
Cite
Cite